Skip to main content

Christopher H Van Dyck

NIH Rank #198
  • Top 1% Funded
  • Program Leader
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1937838Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Radiology

NIH Funding · FY2024

Linked Award Amount
$14.1M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#198
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Christopher H Van Dyck. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Christopher H Van Dyck as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG065248-03R01
    Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months
    $13.1M
    award amount
  • 5R01AG065474-05R01
    Validation of Fluorine-18 radioligand for PET imaging of synaptic density in Alzheimer's disease
    $764.4K
    award amount
  • 5P30AG066508-05P30
    Yale Alzheimer Disease Research Center
    $189K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Christopher H Van Dyck as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Cognition Therapeutics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #198
  8. 2024
    Entered Top 25% Nationally
    Ranked #198
  9. 2024
    Entered Top 10% Nationally
    Ranked #198
  10. 2024
    Entered Top 5% Nationally
    Ranked #198
  11. 2024
    Entered Top 1% Nationally
    Ranked #198
  12. 2025
    $25M Cumulative Funding
  13. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  14. 2025
    R01 Grant Holder
  15. 2025
    Program/Center Grant Leader